ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
Antonino Spinelli(Istituti di Ricovero e Cura a Carattere Scientifico), Yves Panís(Clinique Hartmann), Johan Burisch(University of Copenhagen), Stefanos Bonovas(Humanitas University), Theodore Lytras(National Public Health Organization), Javier P. Gisbert(Hospital Universitario de La Princesa), Gionata Fiorino(Carlo Forlanini Hospital), Vito Annese(Nuovo Ospedale San Giovanni di Dio), Hannah Gordon(University of Oxford), Gianluca Pellino(Universitat Autònoma de Barcelona), Michel Adamina(University of Fribourg), Glen Doherty(University College Dublin), Torsten Kucharzik(Klinikum Lüneburg), Bram Verstockt(Universitair Ziekenhuis Leuven), Piotr Eder(Poznan University of Medical Sciences), Nurulamin M Noor(Cambridge School), Stefan D. Holubar(American Society of Colon and Rectal Surgeons), Ivan Lyutakov(Queen Giovanna Hospital), Daniele Piovani(Humanitas University), María Chaparro(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Tim Raine(National Health Service), Charlotte Hedin(Karolinska University Hospital), Catarina Fidalgo(Hospital Beatriz Ângelo), Francesco Selvaggi(University of Campania "Luigi Vanvitelli"), Oliver Bachmann(Medizinische Hochschule Hannover), Marietta Iacucci(University Hospitals Birmingham NHS Foundation Trust), Edoardo Savarino(University of Padua), Konstantinos Κarmiris(The General Hospital of Heraklion "Venizeleio-Pananio"), Dominik Bettenworth(University Hospital Münster), Uri Kopylov(Sheba Medical Center), Paolo Gionchetti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Pierre Ellul(Mater Dei Hospital), Péter L. Lakatos(McGill University), Κωνσταντίνος Κατσάνος(University of Ioannina), Wladyslawa Czuber‐Dochan(King's College London)
Cited by 540
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Management of <i>Helicobacter pylori</i> infection—the Maastricht IV/ Florence Consensus Report
|Gut|2012|2.3k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k